Position in DXCM
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$282,735
+$80,108 QoQ
Shares Held
4,198
+37.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#655
of 966 holders
Holding Since
Dec 2024
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Capital Investment Advisors, LLC holds $5,451,048 across 7 Medical Devices names. DXCM ranks #6 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
26,042 | $2,363,051 | |
| 2 | SYK |
Stryker Corp
|
3,217 | $1,012,840 | |
| 3 | MDT |
Medtronic plc
|
10,136 | $792,939 | |
| 4 | BSX |
Boston Scientific Corp
|
9,904 | $422,702 | |
| 5 | GEHC |
GE HealthCare Technologies Inc.
|
5,759 | $368,633 | |
| 6 | DXCM |
Dexcom Inc
This page
|
4,198 | $282,735 | |
| 7 | EW |
Edwards Lifesciences Corp
|
2,301 | $208,148 |
All Filings in DXCM
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $282,735 | 4,198 | Shares | Sole | 2026-08-06 | |
| 2025-12-31 | $202,627 | 3,053 | Shares | Sole | 2026-01-13 | |
| 2025-06-30 | $247,816 | 2,839 | Shares | Sole | 2025-07-17 | |
| 2024-12-31 | $205,934 | 2,648 | Shares | Sole | 2025-01-13 | |
| No filing history on record for this holder in this stock. | ||||||